platycodin d has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| An, SE; Chung, WY; Jung, MJ; Kim, KR; Lee, SK; Park, J; Park, KK; Son, JA; Son, SH; Yang, HJ | 1 |
| Chen, HZ; Fang, C; Gao, YG; Guan, YY; Liu, HJ; Liu, YR; Lu, Q; Luan, X; Xu, JR; Zhao, M | 1 |
| Khan, M; Ma, T; Maryam, A; Mehmood, T; Zhang, H | 1 |
1 review(s) available for platycodin d and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Killing cancer with platycodin D through multiple mechanisms.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Cell Transformation, Neoplastic; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Saponins; Triterpenes | 2016 |
2 other study(ies) available for platycodin d and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Platycodin D Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Blocking the Activation of Mitogen-Activated Protein Kinases and the Production of Interleukin-8.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-8; Mice; Neovascularization, Pathologic; Saponins; Triterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2022 |
Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
Topics: Angiogenesis Inhibitors; Animals; Campanulaceae; Cell Line, Tumor; Cell Survival; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Saponins; Signal Transduction; Triterpenes; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2014 |